Neurology 2002;58:527-536
© 2002 American Academy of Neurology
Expedited Publication
Treatment of ADHD in children with tics
A randomized controlled trial
The Tourette’s Syndrome Study Group
*See the Appendix on page 535 for a listing of the members of the Tourette’s Syndrome Study Group.
Address correspondence and reprint requests to Dr. Roger Kurlan, Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642–8673; e-mail: Kurlan{at}neuron.mct.rochester.edu
Background: The treatment of children with attention deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) has been problematic because methylphenidate (MPH)—the most commonly used drug to treat ADHD—has been reported to worsen tics and because clonidine (CLON)—the most commonly prescribed alternative—has unproven efficacy.
Methods: The authors conducted a multicenter, randomized, double-blind clinical trial in which 136 children with ADHD and a chronic tic disorder were randomly administered CLON alone, MPH alone, combined CLON + MPH, or placebo (2 x 2 factorial design). Each subject participated for 16 weeks (weeks 1–4 CLON/placebo dose titration, weeks 5–8 added MPH/placebo dose titration, weeks 9–16 maintenance therapy).
Results: Thirty-seven children were administered MPH alone, 34 were administered CLON alone, 33 were administered CLON + MPH, and 32 were administered placebo. For our primary outcome measure of ADHD (Conners Abbreviated Symptom Questionnaire–Teacher), significant improvement occurred for subjects assigned to CLON (p < 0.002) and those assigned to MPH (p < 0.003). Compared with placebo, the greatest benefit occurred with combined CLON + MPH (p < 0.0001). CLON appeared to be most helpful for impulsivity and hyperactivity; MPH appeared to be most helpful for inattention. The proportion of individual subjects reporting a worsening of tics as an adverse effect was no higher in those treated with MPH (20%) than those being administered CLON alone (26%) or placebo (22%). Compared with placebo, measured tic severity lessened in all active treatment groups in the following order: CLON + MPH, CLON alone, MPH alone. Sedation was common with CLON treatment (28% reported moderate or severe sedation), but otherwise the drugs were tolerated well, including absence of any evident cardiac toxicity.
Conclusions: Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics. Prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.
This article has been cited by other articles:
|
|
|
|
 
G. Bates
Drug treatments for attention-deficit hyperactivity disorder in young people
Adv. Psychiatr. Treat.,
May 1, 2009;
15(3):
162 - 171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Nair and S. Mahadevan
Randomised Controlled Study-efficacy of Clonidine versus Carbamazepine in Children with ADHD
J Trop Pediatr,
April 1, 2009;
55(2):
116 - 121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Gadow, E. E. Nolan, J. Sverd, J. Sprafkin, and J. Schneider
Methylphenidate in Children With Oppositional Defiant Disorder and Both Comorbid Chronic Multiple Tic Disorder and ADHD
J Child Neurol,
September 1, 2008;
23(9):
981 - 990.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Focus,
July 1, 2008;
6(3):
401 - 426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Spencer, F. R. Sallee, D. L. Gilbert, D. W. Dunn, J. T. McCracken, B. J. Coffey, C. L. Budman, R. K. Ricardi, H. L. Leonard, A. J. Allen, et al.
Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome
J Atten Disord,
January 1, 2008;
11(4):
470 - 481.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. G. Wood, J. L. Crager, C. M. Delap, and K. D. Heiskell
Literature Review: Beyond Methylphenidate: Nonstimulant Medications for Youth With ADHD
J Atten Disord,
November 1, 2007;
11(3):
341 - 350.
[Abstract]
[PDF]
|
|
|
|
|
|
|
References
PsychiatryOnline CME,
May 1, 2007;
2007(1):
2 - 2.
[Full Text]
|
|
|
|
|
|
|
B. H. Levine and R. C. Albucher
Patient Management Exercise FOR PSYCHOPHARMACOLOGY
Focus,
September 1, 2006;
4(4):
496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gaze, H. O. Kepley, and J. T. Walkup
Co-occurring Psychiatric Disorders in Children and Adolescents With Tourette Syndrome
J Child Neurol,
August 1, 2006;
21(8):
657 - 664.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Gilbert
Treatment of Children and Adolescents With Tics and Tourette Syndrome
J Child Neurol,
August 1, 2006;
21(8):
690 - 700.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. L. Gilbert, Z. Wang, F. R. Sallee, K. R. Ridel, S. Merhar, J. Zhang, T. D. Lipps, C. White, N. Badreldin, and E. M. Wassermann
Dopamine transporter genotype influences the physiological response to medication in ADHD
Brain,
August 1, 2006;
129(8):
2038 - 2046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Gilbert and C. R. Buncher
Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette's Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses
J Neuropsychiatry Clin Neurosci,
August 1, 2005;
17(3):
324 - 332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Wolraich, C. J. Wibbelsman, T. E. Brown, S. W. Evans, E. M. Gotlieb, J. R. Knight, E. C. Ross, H. H. Shubiner, E. H. Wender, and T. Wilens
Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications
Pediatrics,
June 1, 2005;
115(6):
1734 - 1746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C R Steer
Managing attention deficit/hyperactivity disorder: unmet needs and future directions
Arch. Dis. Child.,
February 1, 2005;
90(suppl_1):
i19 - i25.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Rappley
Attention Deficit-Hyperactivity Disorder
N. Engl. J. Med.,
January 13, 2005;
352(2):
165 - 173.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J S Stern, S Burza, and M M Robertson
Gilles de la Tourette's syndrome and its impact in the UK
Postgrad. Med. J.,
January 1, 2005;
81(951):
12 - 19.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Becker, M. Holtmann, M. El-Faddagh, and M. H. Schmidt
Separation Anxiety Triggered by Atypical Neuroleptic Medication in an Adolescent with Tourette's Syndrome
Clinical Child Psychology and Psychiatry,
October 1, 2004;
9(4):
597 - 603.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. M. Kanner and D. W. Dunn
Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy
J Child Neurol,
August 1, 2004;
19(1_suppl):
S65 - S72.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Bhatara, M. Feil, K. Hoagwood, B. Vitiello, and B. Zima
National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge
J Atten Disord,
May 1, 2004;
7(4):
217 - 226.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. J. Safer, J. M. Zito, and S. dosReis
Concomitant Psychotropic Medication for Youths
Am J Psychiatry,
March 1, 2003;
160(3):
438 - 449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Gilbert, L. Dure, G. Sethuraman, D. Raab, J. Lane, and F. R. Sallee
Tic reduction with pergolide in a randomized controlled trial in children
Neurology,
February 25, 2003;
60(4):
606 - 611.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Efron, H. Hiscock, J. R. Sewell, N. E. Cranswick, A. L. A. Vance, Y. Tyl, and E. S. L. Luk
Prescribing of Psychotropic Medications for Children by Australian Pediatricians and Child Psychiatrists
Pediatrics,
February 1, 2003;
111(2):
372 - 375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. L. Schlaggar and J. W. Mink
Movement Disorders in Children
Pediatr. Rev.,
February 1, 2003;
24(2):
39 - 51.
[Full Text]
[PDF]
|
|
|
|
|
|
|
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs.,
January 1, 2003;
6(1):
e1 - 1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Goldberg
Clonidine and methylphenidate were effective for attention deficit hyperactivity disorder in children with comorbid tics
Evid. Based Med.,
September 1, 2002;
7(5):
157 - 157.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Clonidine Plus Methylphenidate for ADHD and Tics in Children
Journal Watch Neurology,
June 27, 2002;
2002(627):
5 - 5.
[Full Text]
|
|
|
|
|
|
|
Treatment of Children with ADHD and Tic Disorders
Journal Watch Pediatrics and Adolescent Medicine,
June 10, 2002;
2002(610):
11 - 11.
[Full Text]
|
|
|
|
|
|
|
J. G. Millichap
Efficacy and Safety of Methylphenidate for ADHD with Tics
AAP Grand Rounds,
May 1, 2002;
7(5):
49 - 50.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Goetz and V. K. Hinson
Therapies for Movement Disorders
Arch Neurol,
May 1, 2002;
59(5):
699 - 702.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Effective Treatments for Comorbid Tics and ADHD?
Journal Watch Psychiatry,
April 10, 2002;
2002(410):
7 - 7.
[Full Text]
|
|
|
|
|
|
|
R. Nass and S. Bressman
Attention deficit hyperactivity disorder and Tourette syndrome: What's the best treatment?
Neurology,
February 26, 2002;
58(4):
513 - 514.
[Full Text]
[PDF]
|
|
|
|
